Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 638,373Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 147NOVO

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8129343

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209637

Patent Use Code : U-2202

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-05

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8536122

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-20

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 9278123

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8129343

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-05

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8536122

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-20

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 9278123

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8129343

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-05

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 9278123

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8129343

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-05

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

SEMAGLUTIDE

US Patent Number : 8536122

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213051

Patent Use Code : U-2628

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-03-20

blank